Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mudit K Jain
AddedMar 31, 2024
UpdatedMay 31, 2026
Mudit K Jain

Mudit K Jain

Co-Founder, Treo Ventures

CrunchbaseLinkedIn

Mudit K Jain's Career

Treo Ventures
Treo Ventures
Co-Founder
Cvrx
Cvrx

Minneapolis, MN, US

Board Member· Board
ShiraTronics
ShiraTronics

Minneapolis, MN, US

Board Member· Board
Neuspera Medical
Neuspera Medical

San Jose, CA, US

Board Member· Board
NeoChord
NeoChord

St. Louis Park, MN, US

Board Member· Board
Johns Hopkins University
Johns Hopkins University

Baltimore, MD, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mudit K Jain's Career

Treo Ventures
Treo Ventures
Investment Firm82018
Co-Founder

Leadership at Treo Ventures

Brad ValeBrad ValeCo-Founder
Cvrx
Cvrx
Public$390.6M1602001Minneapolis, MN, US
Board Member· Board

Leadership at Cvrx

Jim ShapiroJim ShapiroBoard Member
Nadim YaredNadim YaredBoard Member
Joseph P. SlatteryJoseph P. SlatteryBoard Member
Geoff PardoGeoff PardoBoard Member
Josep Ll. SanfeliuJosep Ll. SanfeliuBoard Member
John M NehraJohn M NehraBoard Member

Similar to Cvrx

BarologicsBarologicsCarver, MN, USMedical Devicesest. 2017BarologicsCarver, MN, US · est. 2017

Innovative medical tech company in Carver, MN treating hypertension with disruptive technology.

$11.5M6
CardieXCardieXItasca, IL, USHealthcare, Medical Devicesest. 2005CardieXItasca, IL, US · est. 2005

CardieX: A global health tech firm specializing in hypertension and cardiovascular disease solutions.

Public · $75k36
Vascular DynamicsVascular DynamicsMountain View, CA, USMedical Devices, Stentsest. 2008Vascular DynamicsMountain View, CA, US · est. 2008

Vascular Dynamics: US-based medical product provider specializing in stent implants for hypertension.

$105.1M24
MvrxMvrxBelmont, CA, USMedical Devicesest. 2009MvrxBelmont, CA, US · est. 2009

MVRx: A medical device company offering ARTO System, an innovative therapy for heart failure and mitral valve regurgitation.

$5.9M30
ShiraTronics
ShiraTronics
$49.7M312018Minneapolis, MN, US
Board Member· Board

Leadership at ShiraTronics

Lynn ElliottLynn ElliottCEO
Casey TanseyCasey TanseyBoard Member
Joyce EronyJoyce EronyBoard Member
Neuspera Medical
Neuspera Medical
$111.9M312013San Jose, CA, US
Board Member· Board

Leadership at Neuspera Medical

Milton M. MorrisMilton M. MorrisBoard Member
Adam FineAdam FineBoard Member
Steffen HovardSteffen HovardCEO
Alexander YehAlexander YehFounder
Lori HuLori HuBoard Member
NeoChord
NeoChord
$89.9M242009St. Louis Park, MN, US
Board Member· Board

Leadership at NeoChord

Nicole J WalkerNicole J WalkerBoard Member
Kyle SalyersKyle SalyersBoard Member
David ChungDavid ChungCEO
John SeabergJohn SeabergFounder
Andrew ElbardissiAndrew ElbardissiBoard Member
Jim BaumgardtJim BaumgardtBoard Member

Similar to NeoChord

Cardiac DimensionsCardiac DimensionsKirkland, WA, USMedical Devicesest. 2001Cardiac DimensionsKirkland, WA, US · est. 2001

US-based Cardiac Dimensions develops global medical devices for heart failure and mitral valve treatment.

Public · $209.7M62
Nectero MedicalNectero MedicalDover, DE, USMedical Devicesest. 2017Nectero MedicalDover, DE, US · est. 2017

Nectero Medical: Innovating treatments to stabilize and prevent abdominal aortic aneurysms.

$19.5M14
NeocisNeocisMiami, FL, USSurgical Robotsest. 2009NeocisMiami, FL, US · est. 2009

Neocis: Revolutionizing dental surgery with advanced, robot-assisted implant technology.

$183.1M175
NicoNicoIndianapolis, IN, USMedical Devicesest. 2007NicoIndianapolis, IN, US · est. 2007

NICO Corp: Global provider of innovative medical devices for minimally invasive neuro and spinal surgeries.

$68.1M104
Johns Hopkins University
Johns Hopkins University
Nonprofit$186.5M19.5k1876Baltimore, MD, US
Board Member· Board

Leadership at Johns Hopkins University

Ronald J. DanielsRonald J. DanielsBoard Member
Warren GraysonWarren GraysonBoard Member
Daniel Coit GilmanDaniel Coit GilmanFounder
Paul RabilPaul RabilBoard Member
Thomas HaineThomas HaineBoard Member
Lou ForsterLou ForsterBoard Member

People Similar to Mudit K Jain

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · DunamuJames ArcherJames ArcherCo-Founder · NexacoreTed LoveTed LoveBoard Member · SeagenAbdon NacifAbdon NacifCo-Founder · NexuMark HanchettMark HanchettBoard Member · NxuPierre SchurmannPierre SchurmannFounder · Bossa Nova InvestimentosChris HibberdChris HibberdBoard Member · Astute Medical